CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $621,000 | -49.5% | 200,943 | +0.7% | 0.00% | – |
| Q4 2021 | $1,229,000 | +5.1% | 199,530 | -10.7% | 0.00% | – |
| Q3 2021 | $1,169,000 | -3.4% | 223,466 | +16.9% | 0.00% | – |
| Q2 2021 | $1,210,000 | -72.3% | 191,101 | -66.2% | 0.00% | -100.0% |
| Q1 2021 | $4,365,000 | +9.2% | 564,567 | -7.5% | 0.00% | 0.0% |
| Q4 2020 | $3,998,000 | -4.7% | 610,396 | -3.3% | 0.00% | -50.0% |
| Q3 2020 | $4,196,000 | -30.4% | 630,919 | -12.8% | 0.00% | 0.0% |
| Q2 2020 | $6,029,000 | +9.0% | 723,801 | +0.4% | 0.00% | -33.3% |
| Q1 2020 | $5,530,000 | -5.2% | 720,968 | +2.7% | 0.00% | +50.0% |
| Q4 2019 | $5,836,000 | +6.4% | 702,308 | -5.6% | 0.00% | 0.0% |
| Q3 2019 | $5,487,000 | -34.3% | 743,586 | -0.1% | 0.00% | -33.3% |
| Q2 2019 | $8,352,000 | – | 744,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners IX LLC | 4,244,381 | $43,378,000 | 100.00% |
| VHCP Management II, LLC | 577,831 | $5,905,000 | 3.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 71,366 | $729,000 | 2.45% |
| Casdin Capital, LLC | 234,179 | $2,392,000 | 2.38% |
| BVF INC/IL | 606,138 | $6,192,000 | 1.32% |
| Opaleye Management Inc. | 160,000 | $1,634,000 | 1.09% |
| Redmile Group, LLC | 733,899 | $7,497,000 | 0.72% |
| VHCP Management, LLC | 64,200 | $656,000 | 0.68% |
| Montecito Bank & Trust | 146,544 | $1,497,000 | 0.63% |
| Cormorant Asset Management, LP | 371,636 | $3,796,000 | 0.54% |